Novartis AG
(NYSE : NVS)

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.92%158.010.7%$1348.71m
PFEPfizer Inc. -0.89%33.520.9%$1215.71m
BMYBristol-Myers Squibb Co. -1.35%61.261.0%$862.91m
MRKMerck & Co., Inc. -2.73%72.580.7%$818.60m
ABBVAbbVie, Inc. 0.28%107.631.9%$796.41m
LLYEli Lilly & Co. 0.43%204.691.1%$749.41m
AZNAstraZeneca Plc -1.08%48.381.2%$499.92m
GSKGlaxoSmithKline Plc -2.24%33.610.2%$268.95m
NVSNovartis AG -0.87%85.960.2%$176.78m
SNYSanofi 0.20%45.890.2%$170.59m
VTRSViatris, Inc. -1.33%14.850.0%$143.27m
VERUVeru, Inc. -3.22%13.820.0%$113.90m
CVACCureVac NV 1.43%94.300.0%$107.31m
NVONovo Nordisk A/S -1.47%71.280.1%$90.64m
VYNEVYNE Therapeutics, Inc. -5.45%7.460.0%$88.66m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.